Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Medical Research South
mi
from
Charleston, SC
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Medical Research South
mi
from
Charleston, SC
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Radiant Research
mi
from
Greer, SC
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Radiant Research
mi
from
Greer, SC
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Volunteer Research Group
mi
from
Knoxville, TN
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Volunteer Research Group
mi
from
Knoxville, TN
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Family Medical Associates of Texas
mi
from
Allen, TX
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Family Medical Associates of Texas
mi
from
Allen, TX
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Premier Family Physicians
mi
from
Austin, TX
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Premier Family Physicians
mi
from
Austin, TX
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Radiant Research, Inc.
mi
from
Dallas, TX
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Radiant Research, Inc.
mi
from
Dallas, TX
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Village Health Center
mi
from
Plano, TX
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Village Health Center
mi
from
Plano, TX
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Doctors of Internal Medicine
mi
from
Plano, TX
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Doctors of Internal Medicine
mi
from
Plano, TX
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Plano Internal Medicine
mi
from
Plano, TX
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Plano Internal Medicine
mi
from
Plano, TX
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Radiant Research, Inc
mi
from
San Antonio, TX
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Radiant Research, Inc
mi
from
San Antonio, TX
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Radiant Research, Inc.
mi
from
Murray, UT
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Radiant Research, Inc.
mi
from
Murray, UT
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Radiant Research, Inc.
mi
from
Saint Louis, MO
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Radiant Research, Inc.
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated:  4/3/2018
Radiant Research, Inc.
mi
from
Cincinnati, OH
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
A Study of Two Doses of LAsMiditan (100 mg and 200 mg) Compared to Placebo in the AcUte Treatment of MigRAIne: A Randomized, Double-blind, Placebo-controlled Parallel Group Study
Status: Enrolling
Updated: 4/3/2018
Radiant Research, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
An Open-Label Phase 1 Study to Establish the Pharmacokinetics and Safety of Sumatriptan Succinate Administered Via the Sofusa™ DoseConnect™ System at Escalating Doses Compared to Oral Imitrex® Single 100 mg Dose in Healthy Subjects
Status: Enrolling
Updated:  4/4/2018
Carolina Phase 1 Research, LLC
mi
from
Raleigh, NC
Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002)
An Open-Label Phase 1 Study to Establish the Pharmacokinetics and Safety of Sumatriptan Succinate Administered Via the Sofusa™ DoseConnect™ System at Escalating Doses Compared to Oral Imitrex® Single 100 mg Dose in Healthy Subjects
Status: Enrolling
Updated: 4/4/2018
Carolina Phase 1 Research, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
Investigator Initiated Investigational New Drug Application to Study the Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
Status: Enrolling
Updated:  4/5/2018
UNC Hospitals
mi
from
Chapel Hill, NC
Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
Investigator Initiated Investigational New Drug Application to Study the Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease
Status: Enrolling
Updated: 4/5/2018
UNC Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Frovatriptan and Menstrual Migraine
Mapping CNS Changes to Frovatriptan Administration in Acute Treatment of Prodrome or Preventative Treatment of Menstrual Migraine (MM)
Status: Enrolling
Updated:  4/10/2018
Neuroimaging Center, McLean Hospital
mi
from
Belmont, MA
Frovatriptan and Menstrual Migraine
Mapping CNS Changes to Frovatriptan Administration in Acute Treatment of Prodrome or Preventative Treatment of Menstrual Migraine (MM)
Status: Enrolling
Updated: 4/10/2018
Neuroimaging Center, McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Intervention for Sleep and Pain in Youth
Intervention for Sleep and Pain in Youth: A Feasibility Study of Cognitive-Behavioral Intervention
Status: Enrolling
Updated:  4/17/2018
Seattle Children'S Research Institute
mi
from
Seattle, WA
Intervention for Sleep and Pain in Youth
Intervention for Sleep and Pain in Youth: A Feasibility Study of Cognitive-Behavioral Intervention
Status: Enrolling
Updated: 4/17/2018
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Timolol Eye Drops in the Treatment of Acute Migraine Headache
Timolol Eye Drops in the Treatment of Acute Migraine Headache
Status: Enrolling
Updated:  4/22/2018
Truman Medical Center
mi
from
Kansas City, MO
Timolol Eye Drops in the Treatment of Acute Migraine Headache
Timolol Eye Drops in the Treatment of Acute Migraine Headache
Status: Enrolling
Updated: 4/22/2018
Truman Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pain Biomarker Study
The Pain Biomarker Study: Changes in Circulating Pain Signalling Molecules With Activation of Pain Receptors
Status: Enrolling
Updated:  4/26/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Pain Biomarker Study
The Pain Biomarker Study: Changes in Circulating Pain Signalling Molecules With Activation of Pain Receptors
Status: Enrolling
Updated: 4/26/2018
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials